This combination leverages the complementary mechanisms of two peptides: CJC-1295 (No DAC) , a GHRH analog that stimulates endogenous growth hormone release via the pituitary gland, and Ipamorelin , a selective growth hormone secretagogue that targets the ghrelin (GHS-R1a) receptor
Calzada Limited press release (26 April 2013)
BPC-157 shows unusual oral stability and may provide some benefit orally, but TB-500 requires injection
Gut-related improvements (reduced bloating, discomfort) may begin
Suicidal Ideation and Other Rare Undesirable Effects With the expanding role in diabetes and obesity, as well as potential extending therapeutic uses in the neurological area (e.g., stroke, neurodegenerative disorders, alcohol- and substance-use disorders), rare side effects have recently emerged
LR3 Insulin Like Growth Factor-1 Human Recombinant